MedPath

To Compare the Efficacy of Harmal capsule versus Methi capsule in the Managment of Primary dysmenorrhea (Kashtartava)

Phase 3
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2024/07/071499
Lead Sponsor
Mahatma Gandhi Ayurved College Salod Wardha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Unmarried women between the age of 16 and 30 years old.

Patient willing to participate with Written informed consent.

Female patients who have experienced pain during their periods for more than two months in a row.

Exclusion Criteria

Women less then16 years and above 30 years

Women with any pelvic pathology and irregular periods.

Patients with a history of other health problems that might affect the treatment process.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath